US Broker Ratings

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: 26% Potential Upside and Strong Buy Ratings Spark Investor Interest

GE HealthCare Technologies Inc. (GEHC) stands as a significant player in the healthcare industry, particularly within the health information services sector. With a market capitalization of..

The Cooper Companies, Inc. (COO): Investor Outlook with 33.90% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a significant player in the healthcare sector, specifically in the medical instruments and supplies industry, offers a compelling opportunity for..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: High Analyst Confidence and a Promising 76% Upside Potential

BridgeBio Pharma, Inc. (BBIO), a leading player in the biotechnology sector, is capturing investor attention with its innovative approach to treating genetic diseases and cancers. With..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring an 18% Upside Potential with Strong Buy Ratings

For investors looking to navigate the healthcare sector, Molina Healthcare Inc (NYSE: MOH) stands out as a compelling opportunity, particularly in light of its robust growth..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 29% Potential Upside in the Medical Device Sector

Teleflex Incorporated (NYSE: TFX), a notable player in the healthcare sector, has captured attention with its diversified portfolio of single-use medical devices. With a current market..

The Cigna Group (CI) Stock Analysis: A Healthcare Giant with an 18.74% Potential Upside

For investors on the lookout for promising opportunities in the healthcare sector, The Cigna Group (NYSE: CI) offers an intriguing prospect. With a market capitalization of..

Summit Therapeutics Inc. (SMMT): Biotech Stock with a 47% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) is capturing the attention of investors within the biotechnology sector, not only for its groundbreaking approach to drug development but also..

Alnylam Pharmaceuticals, Inc. (ALNY): Investor Outlook Reveals 10.57% Potential Upside and Robust Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, continues to intrigue investors with its promising pipeline and strategic collaborations. Headquartered in Cambridge, Massachusetts,..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with 22.85% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is carving a niche in the biotechnology sector with its innovative enzyme-based drug delivery solutions. With a market capitalization of $6.72..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Growth Potential with a 13.80% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, has been capturing investor attention with its innovative medical instruments and supplies. Based..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 70.97% Potential Upside

Investors on the lookout for opportunities in the biotechnology sector should consider Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a company headquartered in Dublin, Ireland. Specializing in developing..

BioNTech SE (BNTX) Stock Analysis: A 34.66% Potential Upside Amidst Biotech Challenges

BioNTech SE (BNTX), a prominent player in the biotechnology sector, has been a focal point for investors with its promising pipeline of immunotherapies aimed at combating..

HCA Healthcare, Inc. (HCA) Stock Analysis: Robust Revenues and Analyst Confidence Highlight Investment Potential

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable entity in the healthcare sector, particularly within the medical care facilities industry. With a robust market capitalization..

BrightSpring Health Services, I (BTSG)

⚠️ No article content returned.

..

Repligen Corporation (RGEN) Stock Analysis: Navigating a Potential 54.99% Upside with Strong Buy Ratings

For investors keen on the healthcare sector, Repligen Corporation (NASDAQ: RGEN) presents a compelling case for consideration, particularly with its attractive potential upside of nearly 55%...

Centene Corporation (CNC) Stock Analysis: A Healthcare Leader with 38.44% Potential Upside

Investors eyeing the healthcare sector should pay close attention to Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry. With a market capitalization..

Natera, Inc. (NTRA) Stock Analysis: Unpacking a 25% Upside Potential in the Diagnostics Arena

Natera, Inc. (NASDAQ: NTRA) stands prominently in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Austin, Texas, this innovative company has carved..

Legend Biotech Corporation (LEGN): Investor Outlook Highlights 165% Potential Upside Amidst Strong Buy Ratings

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its promising potential upside of 165.40%, driven by an impressive array of buy ratings..

Ascendis Pharma A/S (ASND) Stock Analysis: Unpacking a 38.64% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND), a Danish biopharmaceutical company, has made headlines in the healthcare sector with its promising therapeutic developments and strategic market positioning. As..

Glaukos Corporation (GKOS) Stock Analysis: A 27% Upside Potential in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector, specifically within the medical devices industry, offers a compelling proposition for investors seeking growth in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds